Phoenicia BioScience & Phoenicia Therapeutics

Gene therapy in a capsule for treatment of serious blood diseases, sickle cell disease and beta thalassemia

  • Stage Product In Development
  • Industry Biotechnology
  • Location Weston, MA, USA
  • Currency USD
  • Founded July 2008
  • Employees 2
  • Incorporation Type C-corp
  • Website http://phobiosci.com

Company Summary

Our company, funded by SBIR/STTR grants, develops therapeutics from bench to bedside. The lead candidate, a therapy for serious orphan blood diseases, co-developed with the NIH, Therapeutics for Rare or Neglected Diseases Program (TRND), is de-risked for safety in other patients and for efficacy in nonhuman primates.

The goal is to conduct our FDA approved clinical trial of the lead and license it and a pipeline to complete development.

Team

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free